Tesa/IPA 6/3mg Spray is a compounded dual-peptide research solution formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Combining a stabilized GHRH receptor agonist with a selective growth hormone secretagogue, each bottle delivers 6mg Tesamorelin Tesamorelin (trans-3-hexenoyl-GHRH) and 3mg Ipamorelin Ipamorelin (`Aib-His-D-2-Nal-D-Phe-Lys-NH2`). Formulated as a stabilized solution, it is designed to investigate the synergistic pathways of pituitary somatotroph secretagogue signaling and lipolysis in mucosal transport models.
HPLC certified
Independent analysis
Highest standard
Full traceability
Tesa/IPA 6/3mg Spray is a compounded somatotropic dual-peptide solution designed to evaluate non-invasive mucosal transport kinetics and synergistic endocrine receptor signaling. This blend combines two high-purity peptides: Tesamorelin (6mg Tesamorelin) for GHRH pathway activation and visceral fat lipolysis, and Ipamorelin (3mg Ipamorelin) for selective ghrelin receptor (GHSR) activation. Unlike standard single-compound powders, this pre-dissolved format enables multi-pathway G-protein coupled receptor studies in a ready-to-use liquid vehicle.
Researchers continue to investigate Tesa/IPA across major areas of metabolic biology, including pulsatile growth hormone synergy, insulin-like growth factor-1 (IGF-1) axis activation, somatic cell regeneration, and visceral fat distribution. The liquid spray format is of high interest because it allows researchers to study the co-permeation and transport kinetics of a large lipidated 44-amino-acid peptide (Tesamorelin) and a small basic pentapeptide (Ipamorelin) across epithelial barriers. Formulated with high-purity research-grade materials and verified by HPLC, Tesa/IPA 6/3mg Spray provides a consistent, pre-dissolved molecular tool to examine somatotropic synergy under controlled laboratory conditions.
Tesa/IPA 6/3mg Spray is a research-grade synthetic dual-peptide solution developed for laboratory investigations involving synergistic somatotropic signaling, metabolic regulation, and non-invasive delivery methods. The blend contains two distinct, high-purity research peptides combined in a pre-metered aqueous vehicle: Tesamorelin (6mg Tesamorelin) and Ipamorelin (3mg Ipamorelin). As an investigational compound, Tesa/IPA is studied for its ability to activate multiple growth hormone releasing pathways simultaneously, targeting the GHRH receptor (GHRHR) and the Growth Hormone Secretagogue Receptor (GHSR) on somatotroph cells.
From a molecular research perspective, Tesa/IPA Spray provides a valuable model for investigating the transport kinetics of diverse peptide structures across epithelial cell layers. By combining a large, lipidated 44-amino-acid peptide (Tesamorelin) and a small, basic pentapeptide (Ipamorelin), researchers can evaluate how peptides of vastly different molecular weights and lipophilicity profiles co-permeate membranes. This spray format is particularly suited for research involving nasal mucosal cell lines.
Current laboratory investigations examine the synergistic interaction of these two growth hormone pathways in somatotroph cells. Tesamorelin binds to GHRHR, activating the G-alpha-s cAMP/PKA cascade to stimulate GH transcription. Simultaneously, Ipamorelin binds to GHSR (the ghrelin receptor), activating the PLC/IP3 pathway to mobilize intracellular calcium. The convergence of G-protein pathways (cAMP and calcium) drives synergistic, high-potency exocytosis of endogenous growth hormone. Additionally, GHSR activation suppresses hypothalamic somatostatin, removing the somatic brake and allowing GHRH signaling to function at maximal capacity.
Beyond direct pituitary growth hormone secretion, researchers use the Tesa/IPA blend to explore downstream metabolic and lipolysis pathways. Studies evaluate how growth hormone release stimulated by GHRH and GHSR receptor agonists coordinates hepatic insulin-like growth factor-1 (IGF-1) synthesis and release, and how this combined signaling accelerates lipolysis in visceral fat cells. Researchers analyze adipose tissue reduction, lipid profiles, and insulin sensitivity under controlled conditions.
In neurobiology and central nervous system (CNS) research, the intranasal spray format provides an optimized experimental model for studying direct blood-brain barrier (BBB) bypass. Researchers evaluate whether mucosal delivery via olfactory or trigeminal nerve pathways facilitates direct transport of GHRH and GHSR ligands to hypothalamic and pituitary structures. This allows the study of central somatic regulation, growth hormone releasing hormone receptor synergy, and feedback mechanisms without systemic variables.
Each bottle of Tesa/IPA Spray is manufactured using precise solid-phase peptide synthesis (SPPS) for each peptide component, followed by purification and analytical blending. The final solution is calibrated in a stabilized, sterile buffered liquid carrier to prevent peptide degradation or structural oxidation. Quality control protocols include reverse-phase HPLC for purity verification of each peptide and liquid chromatography-mass spectrometry (LC-MS) for molecular identity confirmation.
To preserve the stability of the dual-peptide solution, Tesa/IPA Spray should be stored under refrigeration (2°C to 8°C) and protected from light. Because lipidated and basic peptides can undergo degradation or peptide cleavage in aqueous environments over time, maintaining refrigerated storage and minimizing atmospheric exposure is critical to preserving peptide integrity. Proper handling supports consistent concentration and analytical reproducibility across laboratory protocols.
Scientific interest in dual-peptide blends continues to expand as researchers seek to characterize peptide stability, receptor cross-talk, and transport kinetics. Nevertheless, many aspects of their cellular signaling and epithelial transport remain active areas of scientific inquiry. Ongoing studies continue to refine the understanding of peptide synergy in biological systems. For this reason, Tesa/IPA Spray should be regarded as an investigational compound whose primary value lies in advancing scientific knowledge of somatotropic receptor biology.
Tesa/IPA Spray is supplied exclusively for laboratory research and analytical applications. It is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary use, or diagnostic purposes.
Telomerase enzyme explained: how TERT and TERC maintain telomeres, why it matters in aging and cancer research, plus RUO peptide sourcing. Read the guide.
KLOW peptide research blend is drawing attention across California's research community. Discover its composition, COA basics, and current evidence limits.
Learn what a peptide bond is, how it forms through dehydration synthesis, and why its structure matters for research peptides. Read the full guide now.
(faqs)
